AnnexinA6: a potential therapeutic target gene for extracellular matrix mineralization

被引:6
|
作者
Yang, Jie [1 ]
Pei, Tong [1 ]
Su, Guanyue [1 ]
Duan, Peiyan [1 ]
Liu, Xiaoheng [1 ]
机构
[1] Sichuan Univ, Inst Biomed Engn, West China Sch Basic Med Sci & Forens Med, Chengdu, Peoples R China
基金
中国国家自然科学基金;
关键词
AnnexinA6; Ca2+ regulation; matrix vesicles; extracellular matrix mineralization; osteogenesis; bone regeneration; VESICLE-MEDIATED MINERALIZATION; GROWTH-PLATE CARTILAGE; ARTERIAL CALCIFICATION; VASCULAR CALCIFICATION; ALKALINE-PHOSPHATASE; CELL-PROLIFERATION; NUCLEATIONAL CORE; CRYSTAL-STRUCTURE; MEMBRANE-BINDING; DOWN-REGULATION;
D O I
10.3389/fcell.2023.1201200
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The mineralization of the extracellular matrix (ECM) is an essential and crucial process for physiological bone formation and pathological calcification. The abnormal function of ECM mineralization contributes to the worldwide risk of developing mineralization-related diseases; for instance, vascular calcification is attributed to the hyperfunction of ECM mineralization, while osteoporosis is due to hypofunction. AnnexinA6 (AnxA6), a Ca2+-dependent phospholipid-binding protein, has been extensively reported as an essential target in mineralization-related diseases such as osteoporosis, osteoarthritis, atherosclerosis, osteosarcoma, and calcific aortic valve disease. To date, AnxA6, as the largest member of the Annexin family, has attracted much attention due to its significant contribution to matrix vesicles (MVs) production and release, MVs-ECM interaction, cytoplasmic Ca2+ influx, and maturation of hydroxyapatite, making it an essential target in ECM mineralization. In this review, we outlined the recent advancements in the role of AnxA6 in mineralization-related diseases and the potential mechanisms of AnxA6 under normal and mineralization-related pathological conditions. AnxA6 could promote ECM mineralization for bone regeneration in the manner described previously. Therefore, AnxA6 may be a potential osteogenic target for ECM mineralization.
引用
收藏
页数:13
相关论文
共 50 条
  • [21] Extracellular matrix stiffness: mechanisms in tumor progression and therapeutic potential in cancer
    Meiling Zhang
    Bin Zhang
    Experimental Hematology & Oncology, 14 (1)
  • [22] Potential improvement of lentiviral gene transfer by weakening the extracellular matrix
    Grüter, O
    Kostic, C
    Tekaya, M
    Schorderet, DF
    Zografos, L
    Munier, FL
    Arsenijevic, Y
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2004, 45 : U518 - U518
  • [23] Matrix Metalloproteinases in Kidney Disease: Role in Pathogenesis and Potential as a Therapeutic Target
    Parrish, Alan R.
    MATRIX METALLOPROTEINASES AND TISSUE REMODELING IN HEALTH AND DISEASE: TARGET TISSUES AND THERAPY, 2017, 148 : 31 - 65
  • [24] Matrix metalloproteinase-9 may be a potential therapeutic target in epilepsy
    Yin, P.
    Yang, L.
    Zhou, H. Y.
    Sun, R. P.
    MEDICAL HYPOTHESES, 2011, 76 (02) : 184 - 186
  • [25] NEUTROPHIL EXTRACELLULAR TRAPS: A BIOMARKER AND POTENTIAL THERAPEUTIC TARGET IN CF AIRWAYS INFLAMMATION
    Law, S.
    Hardisty, G.
    Dransfield, I
    Gray, R. D.
    PEDIATRIC PULMONOLOGY, 2019, 54 : S164 - S164
  • [26] Identification of PBK as a hub gene and potential therapeutic target for medulloblastoma
    Deng, Yuhao
    Wen, Huantao
    Yang, Hanjie
    Zhu, Zhengqiang
    Huang, Qiongzhen
    Bi, Yuewei
    Wang, Pengfei
    Zhou, Ming
    Guan, Jianwei
    Zhang, Wangming
    Li, Min
    ONCOLOGY REPORTS, 2022, 48 (01)
  • [27] Pulmonary vascular fibrosis in pulmonary hypertension-The role of the extracellular matrix as a therapeutic target
    Jandl, Katharina
    Radic, Nemanja
    Zeder, Katarina
    Kovacs, Gabor
    Kwapiszewska, Grazyna
    PHARMACOLOGY & THERAPEUTICS, 2023, 247
  • [28] The Development of a Novel Therapeutic Strategy to Target Hyaluronan in the Extracellular Matrix of Pancreatic Ductal Adenocarcinoma
    Kudo, Daisuke
    Suto, Akiko
    Hakamada, Kenichi
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2017, 18 (03)
  • [29] SIRT6: A potential therapeutic target for diabetic cardiomyopathy
    Wu, Tao
    Qu, Yiwei
    Xu, Shengjie
    Wang, Yong
    Liu, Xue
    Ma, Dufang
    FASEB JOURNAL, 2023, 37 (08):
  • [30] Bcl-6 as a potential therapeutic target for bladder cancer
    Furuya, Hideki
    Murakami, Kaoru
    Kim, Nari
    Rosser, Charles J.
    CANCER RESEARCH, 2023, 83 (07)